Personal Capital Advisors Corp Novartis Ag Transaction History

Personal Capital Advisors Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $363,779 - $411,505	-4,541 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $166,971 - $184,632	2,095 Added 85.65%	4,541 $379,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $200,033 - $232,712	2,446 New	2,446 $200,000
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $263,221 - $290,735	-3,088 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $28,056 - $33,085	336 Added 12.21%	3,088 $264,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $23,577 - $28,517	-302 Reduced 9.89%	2,752 $260,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $42,384 - $46,956	516 Added 20.33%	3,054 $266,000
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $65,553 - $73,791	-810 Reduced 24.19%	2,538 $222,000
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $17,455 - $24,455	247 Added 7.97%	3,348 $253,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $261,569 - $295,742	3,101 New	3,101 $294,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

Stay updated on Personal Capital Advisors Corp with notifications on news.